FDA announces new network to focus exclusively on patients

FDA announces new network to focus exclusively on patients
The U.S. Food and Drug Administration has announced the launch of a new interactive tool for educating patients, their advocates, and consumers about the processes involved in medication development.

(HealthDay)—The U.S. Food and Drug Administration has announced the launch of a new interactive tool for educating patients, their advocates, and consumers about the processes involved in medication development.

Since the early 1990s, the FDA has been working directly with patients and their advocates to help them understand about product development and regulation. This includes patient representatives who participate in FDA advisory meetings. Patient input will be more focused and valuable when they better understand how are studied, reviewed, assessed, and brought to market.

The interactive FDA Patient Network website educates patients, their advocates, and consumers about the development of prescription and over-the-counter medications. New channels of communication will be available, including live chats with senior agency officials. With the launch of this website and the increased ability for patients to understand the safety processes involved in drug development, it is hoped that the role of patients can be expanded to a wider audience in new and broader ways.

"I am excited because this new Patient Network website provides a for FDA to follow in making its inner workings transparent to the public," Margaret A. Hamburg, M.D., Commissioner of the FDA, said in a statement. "It ushers in a new era of access and input for patients and consumers that will evolve with the needs of both communities."

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

FDA Web site explains agency operations to public

Jan 12, 2010

(AP) -- The Food and Drug Administration is launching a new Web site explaining its operations to consumers as part of a broader effort to rebrand itself as a more accessible agency.

FDA: Draft guidance issued on abuse-deterrent opioids

Jan 10, 2013

(HealthDay)—The U.S. Food and Drug Administration has issued a draft guidance document to assist the pharmaceutical industry in developing new formulations of opioid drugs with abuse-deterrent properties.

FDA weighs over-the-counter switch for key drugs

Mar 08, 2012

Some of the most widely used prescription drugs, including those to treat cholesterol and high blood pressure, could be available over the counter under a new proposal being weighed by government regulators.

Recommended for you

Health care M&A leads global deal surge

11 hours ago

In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and ...

US approves new, hard-to-abuse hydrocodone pill (Update)

Nov 20, 2014

U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking ...

Soaring generic drug prices draw Senate scrutiny

Nov 20, 2014

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington ...

Only half of patients take their medications as prescribed

Nov 20, 2014

The cost of patients not taking their medications as prescribed can be substantial in terms of their health. Although a large amount of research evidence has tried to address this problem, there are no well-established ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.